Mill Creek Capital Advisors LLC Has $690,000 Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mill Creek Capital Advisors LLC cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,985 shares of the exchange traded fund’s stock after selling 2,732 shares during the period. Mill Creek Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $690,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. Affinity Asset Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 105.4% during the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after purchasing an additional 737,550 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its stake in SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after acquiring an additional 730,000 shares during the period. Mirae Asset Securities USA Inc. acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $55,626,000. Assetmark Inc. lifted its position in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after acquiring an additional 588,489 shares during the period. Finally, Jane Street Group LLC grew its holdings in shares of SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 5.3 %

Shares of SPDR S&P Biotech ETF stock opened at $91.83 on Friday. The company has a 50 day moving average of $98.95 and a 200-day moving average of $96.11. The company has a market cap of $7.00 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $69.32 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.